Effects of Intravenous Dexamethasone on IL-6 Levels in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Background: Cardiopulmonary bypass provokes a systemic inflammatory response in children, with interleukin-6 (IL-6) levels rising rapidly after bypass.Corticosteroids are frequently used to blunt this response, but paediatric evidence remains inconsistent.Objective: To evaluate whether a single intravenous dose of dexamethasone reduces the post-bypass increase in plasma IL-6 and improves early postoperative outcomes in children undergoing cardiac surgery with cardiopulmonary bypass.Methods: This single-centre quasi-experimental study enrolled 46 children aged one month to 12 years undergoing elective repair of congenital heart disease between January 2025 and August 2025.Participants were purposively recruited and alternately allocated to intravenous dexamethasone (1 mg/kg, maximum 10 mg; n=23, 50.0%) or 2 mL normal saline (n=23, 50.0%) after induction of anaesthesia.Plasma IL-6 was measured before drug administration, two hours after cardiopulmonary bypass, and 24 hours after bypass.Haemodynamic variables, oxygen saturation, extubation time, and intensive care unit stay were recorded.Results: The median IL-6 increase from baseline to two hours was lower with dexamethasone than with saline (261.90 pg/mL, interquartile range: 195.0-824.0,versus 447.0 pg/mL, interquartile range: 261.70-1,230.20),but the difference was not statistically significant (p=0.177).At 24 hours, the median change from baseline was 8.20 pg/mL in the dexamethasone group and 13.0 pg/mL in the saline group (p=0.350).Blood pressure, oxygen saturation, and extubation time were comparable.First-postoperative-day heart rate was higher with dexamethasone (143.63 ± 18.93 versus 117.76 ± 19.57beats/min; p=0.001), and median intensive care unit stay was longer (120 versus 95.5 hours; p=0.001).Conclusions: A single dose of intravenous dexamethasone at 1 mg/kg, capped at 10 mg, did not significantly attenuate the IL-6 response after paediatric cardiopulmonary bypass.The higher heart rate and longer intensive care stay observed in the dexamethasone group should be treated as exploratory because allocation was nonrandom and perioperative complexity was not adjusted for.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-10-16
DOI
https://doi.org/10.7759/cureus.118037
Primary Topic
Cardiac and Coronary Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Intravenous Dexamethasone on IL-6 Levels in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Sanjoy Kumar Saha, Sabina Yeasmeen, Rajat Shuvra Das, Md. Ashfak Ahmad et al.
Cureus
Cardiac and Coronary Surgery Techniques
article

Effects of Intravenous Dexamethasone on IL-6 Levels in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Sanjoy Kumar Saha, Sabina Yeasmeen, Rajat Shuvra Das, Md. Ashfak Ahmad, Ponam Saha, Tasnima Ahmed Prima, Mehedi Al-Mahmud, Aklima Sultana Suravi, Arju Meena, Mohammad Mahbubur Rahman
article en

Abstract

Background: Cardiopulmonary bypass provokes a systemic inflammatory response in children, with interleukin-6 (IL-6) levels rising rapidly after bypass.Corticosteroids are frequently used to blunt this response, but paediatric evidence remains inconsistent.Objective: To evaluate whether a single intravenous dose of dexamethasone reduces the post-bypass increase in plasma IL-6 and improves early postoperative outcomes in children undergoing cardiac surgery with cardiopulmonary bypass.Methods: This single-centre quasi-experimental study enrolled 46 children aged one month to 12 years undergoing elective repair of congenital heart disease between January 2025 and August 2025.Participants were purposively recruited and alternately allocated to intravenous dexamethasone (1 mg/kg, maximum 10 mg; n=23, 50.0%) or 2 mL normal saline (n=23, 50.0%) after induction of anaesthesia.Plasma IL-6 was measured before drug administration, two hours after cardiopulmonary bypass, and 24 hours after bypass.Haemodynamic variables, oxygen saturation, extubation time, and intensive care unit stay were recorded.Results: The median IL-6 increase from baseline to two hours was lower with dexamethasone than with saline (261.90 pg/mL, interquartile range: 195.0-824.0,versus 447.0 pg/mL, interquartile range: 261.70-1,230.20),but the difference was not statistically significant (p=0.177).At 24 hours, the median change from baseline was 8.20 pg/mL in the dexamethasone group and 13.0 pg/mL in the saline group (p=0.350).Blood pressure, oxygen saturation, and extubation time were comparable.First-postoperative-day heart rate was higher with dexamethasone (143.63 ± 18.93 versus 117.76 ± 19.57beats/min; p=0.001), and median intensive care unit stay was longer (120 versus 95.5 hours; p=0.001).Conclusions: A single dose of intravenous dexamethasone at 1 mg/kg, capped at 10 mg, did not significantly attenuate the IL-6 response after paediatric cardiopulmonary bypass.The higher heart rate and longer intensive care stay observed in the dexamethasone group should be treated as exploratory because allocation was nonrandom and perioperative complexity was not adjusted for.

Cureus
National Institute of Neurosciences & Hospital (BD), Children's Specialized Hospital (US)
Good health and well-being
Openalex Percentile: Top 10%
Cardiac and Coronary Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.